Source disclosure: February 20, 2026
SUSMED,Inc. [4263.T]
TOKYO, Feb 20 (Pulse News Wire) – Susmed,inc. (4263.T) resolved today to convene an extraordinary shareholders’ meeting on March 13, 2026, to reduce its capital.
The meeting will take place on Monday, May 25, 2026, at 14:00 JST, with further details to be confirmed via electronic notice posted on the company’s website. The reduction in capital, aimed at enhancing flexibility and agility in capital policy, involves transferring ¥107.1 million from the existing capital of ¥117.1 million to the capital reserve fund, reducing the total capital to ¥10 million. Should any outstanding subscription rights be exercised prior to the effective date of the reduction, or should additional shares be issued during the same period, the final adjusted capital amount would be ¥10 million.
This non-cash reduction will not alter the number of issued shares but will reallocate the reduced capital amount to the capital reserve fund without repayment. Key milestones include creditor objection notices due on April 17, 2026, and the final deadline for objections on May 18, 2026. The resolution is contingent upon approval at the scheduled extraordinary shareholders’ meeting on May 25, 2026.
The adjustment is purely an internal reclassification within the equity section of the balance sheet and will have no impact on the company's net assets or performance.
AI-translated content. 🟢 Confidence: High See terms • Original filing